Hanmi Pharm Co Ltd
KRX:128940

Watchlist Manager
Hanmi Pharm Co Ltd Logo
Hanmi Pharm Co Ltd
KRX:128940
Watchlist
Price: 278 000 KRW -1.07% Market Closed
Market Cap: 3.5T KRW
Have any thoughts about
Hanmi Pharm Co Ltd?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

10.3
Current
13.6
Median
13.3
Industry
Lower than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
10.3
=
Enterprise Value
3.7T KRW
/
EBITDA
360B KRW
All Countries
Close

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
10.5
2-Years Forward
EV/EBITDA
10
3-Years Forward
EV/EBITDA
9.1

See Also

Discover More